4-Aminopyridine
Sponsors
University of California, Los Angeles, Columbia University, Coordinación de Investigación en Salud, Mexico, Massachusetts Eye and Ear Infirmary, University of Rochester
Conditions
Carpal Tunnel SyndromeChronicCompression NeuropathyCrush InjuryEpisodic Ataxia Type 2Migraine DisordersMultiple SclerosisNerve Injury
Phase 2
4-Aminopyridine in Episodic Ataxia Type 2
WithdrawnNCT01543750
Updated: 2020-11-16
Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
CompletedNCT01645787
Start: 2012-06-01End: 2015-09-30Updated: 2024-09-03
Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis
CompletedNCT02280096
Start: 2014-10-31End: 2017-02-28Updated: 2019-09-12
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
WithdrawnNCT03578354
Start: 2019-01-31End: 2024-08-31Updated: 2024-07-01
4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy
WithdrawnNCT03658408
Start: 2018-10-03End: 2018-10-30Updated: 2018-11-02
4-aminopyridine Treatment for Nerve Injury
RecruitingNCT03701581
Start: 2021-06-05End: 2028-12-31Target: 70Updated: 2025-12-17
A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma
TerminatedNCT04026568
Start: 2021-08-17End: 2022-07-18Updated: 2022-10-18
4-AP Peripheral Nerve Crossover Trial
RecruitingNCT06003166
Start: 2025-04-21End: 2028-07-31Target: 68Updated: 2025-08-05
4AP for Carpal Tunnel Syndrome (CTS)
Not yet recruitingNCT06294821
Start: 2026-11-01End: 2028-07-01Target: 160Updated: 2026-01-26
4-aminopyridine for Skin Wound Healing
RecruitingNCT06333171
Start: 2025-09-30End: 2028-03-31Target: 150Updated: 2025-09-03